GLP-1 Cold Chain & Temperature Storage Protocol in India

Clinical handling standards for maintaining peptide bio-potency, cold-chain transport, and domestic storage under Indian climatic conditions.

1. Fundamental Storage Rules: 2°C to 8°C Requirement

GLP-1 receptor agonists and dual incretins (such as Semaglutide and Tirzepatide) are synthetic peptide biologics. Unlike traditional chemical tablets, peptides consist of amino acid chains linked by chemical bonds that are sensitive to thermal breakdown and direct ultraviolet light exposure.

  • Unopened / Unused Pens: Must be refrigerated continuously at 2°C to 8°C (36°F to 46°F).
  • Activated / In-Use Pens: After the first injection, most pens can be kept at controlled room temperature (below 30°C) or in the refrigerator for up to 28 to 56 days (depending on the specific manufacturer guidelines).
  • Never Freeze: If a pen accidentally freezes (e.g. pushed against the freezer compartment or back cooling wall), the protein structure denatures. Discard frozen pens immediately; do not attempt to thaw and use.

2. Managing Power Outages & Travel in India

During summer months where ambient temperatures frequently surpass 40°C across North and Central India, handling power interruptions and domestic travel requires planning:

📋 Best Practices for Home Storage:

  • Store pens on the middle shelf of the refrigerator. Avoid the door racks, which experience frequent temperature fluctuations whenever opened.
  • For domestic flights within India, always carry pens in hand luggage with your original doctor's prescription. Never place medication pens in checked baggage where aircraft cargo holds can drop below freezing.
  • Use a validated TSA-compliant medical insulin/peptide travel pouch with frozen gel ice packs for journeys longer than 2 hours.

3. Visual Inspection Before Every Injection

Always inspect the solution through the pen's viewing window before administering a dose:

  • Normal Appearance: The liquid must be completely clear, colorless, and free of visible particles or cloudiness.
  • Signs of Degradation: If the liquid appears cloudy, discolored, viscous, or contains flakes/particles, do not inject. Contact your prescribing clinician for a replacement.